XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Schedule of Stock Options Activity

A summary of the Company’s stock option activity, for nine months ended September 30, 2023, was as follows:

 

 

 

Number of
Options

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Life (Years)

 

 

Aggregate
Intrinsic Value
(in thousands)

 

Outstanding as of December 31, 2022

 

 

13,434,083

 

 

$

0.67

 

 

 

6.77

 

 

$

11,593

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(458,565

)

 

 

0.33

 

 

 

 

 

 

 

Forfeited

 

 

(418,700

)

 

 

2.99

 

 

 

 

 

 

 

Expired

 

 

(59,564

)

 

 

0.26

 

 

 

 

 

 

 

Outstanding as of September 30, 2023

 

 

12,497,254

 

 

$

0.60

 

 

 

5.82

 

 

$

4,151

 

Vested and exercisable as of September 30, 2023

 

 

11,528,748

 

 

$

0.52

 

 

 

5.69

 

 

$

4,034

 

Vested and expected to vest as of September 30, 2023

 

 

12,497,254

 

 

$

0.60

 

 

 

5.82

 

 

$

4,151

 

There were no options granted during the nine months ended September 30, 2023.
Schedule of Restricted Stock Activity

The following table summarizes our RSU activity for the nine months ended September 30, 2023:

 

 

 

Shares

 

 

Weighted Average
Grant Date
Fair Value
per Share

 

Outstanding as of December 31, 2022

 

 

11,945,375

 

 

$

5.22

 

Granted

 

 

23,022,625

 

 

 

1.28

 

Released

 

 

(4,028,417

)

 

 

4.36

 

Forfeited

 

 

(4,795,217

)

 

 

3.80

 

Outstanding as of September 30, 2023

 

 

26,144,366

 

 

$

2.15

 

Schedule of Fair Value Weighted-Average Assumptions The Company estimated the fair value of the market-based PBRSUs award on the grant date using the Monte Carlo simulation model with the following assumptions:

 

 

September 30, 2023

 

Expected term (years)

 

0.5 - 4.7

 

Expected volatility

 

 

70.9

%

Risk-free interest rate

 

 

3.29

%

Dividend yield

 

 

0

%

Share price

 

$

1.02

 

Summary of Stock-Based Compensation Expense

Total stock-based compensation expense by function was as follows (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Cost of revenue

 

$

161

 

 

$

396

 

 

$

858

 

 

$

738

 

Research and development expenses

 

 

3,094

 

 

 

4,177

 

 

 

12,717

 

 

 

13,152

 

General and administrative expenses

 

 

1,654

 

 

 

1,263

 

 

 

3,989

 

 

 

3,767

 

Sales and marketing expenses

 

 

240

 

 

 

304

 

 

 

589

 

 

 

701

 

Total

 

$

5,149

 

 

$

6,140

 

 

$

18,153

 

 

$

18,358